9
Jul
Milestone for BioNTech
325 Million USD for further development of its cancer immunotherapy. Learn more at:
MORE →-
-
22
AprEli Lilly and Avidity Biosciences announce licensing & research cooperation
on combined monoclonal antibodies and oligonucleotide-based therapies for potential new medicines in immunology and other select indications. Read more here:
MORE →